Kit Category: For Individuals

Antegenes® Breast

AnteBC is a genetic test that assesses your risk of developing breast cancer. This test defines personal genetic predisposition for breast cancer. Based on personal risk level, it is possible to give scientific and practical personalised recommendations to prevent or detect breast cancer at an early stage when it is still treatable.

Antegenes® Women

AnteCancerW is a set of genetic tests for women that assess the risk of developing breast cancer, colorectal cancer, and skin melanoma. This test defines personal genetic predisposition for three common cancers. Based on personal risk level, it is possible to give scientific and practical personalised recommendations to prevent or detect cancer at an early stage when it is still treatable.

Invitae BRCA1 and BRCA2 STAT panel

If you have already been diagnosed with cancer, this test is a rapid analysis that can help you make vital decisions about your treatment – particularly if you are considering surgical options.

Invitae Breast Cancer STAT Panel

All of us have a 1 in 2 lifetime risk of cancer, but some common cancers – breast, melanoma, pancreatic, prostate and ovarian – are known to occur more frequently in families, passing from one generation to the next. It’s because certain gene mutations can be inherited – particularly those in BRCA1 and BRCA2 genes – and this test focuses on these, pus another six genes which can indicate additional risk.

Prosigna®

The Prosigna® Breast Cancer Prognostic Gene Signature Assay Prosigna® is a second-generation prognostic test that comprehensively informs treatment decisions in breast cancer patients. The Prosigna® risk of recurrence score adds significant prognostic information to conventional risk factors, including pathological analysis of the patient tumour, and protein markers detected using Immunohistochemistry. It is used by healthcare… Read more »